Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M119,577Revenue $M45,912Net Margin (%)8.1Z-Score2.4
Enterprise Value $M138,059EPS $4.5Operating Margin %11.1F-Score8
P/E(ttm))33.1Cash Flow Per Share $0Pre-tax Margin (%)10.7Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %5.7Quick Ratio0.9Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %3.3Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %4.4ROA % (ttm)5.8Higher Current Ratio y-yY
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)16.8Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M827ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 144.604%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 144.606%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 144.6026%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 144.6046%Reduce -3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 144.6047%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 144.6059%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 144.6054%Add 24.27%46,440
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 144.6064%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 144.6064%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 144.6064%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BAYRY :

    Quarterly/Annual Reports about BAYRY:

      News about BAYRY:

      Articles On GuruFocus.com
      Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
      Zoetis Will Benefit from Industry Trends Oct 07 2014 
      Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
      Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
      We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
      Mallinckrodt Acquired San Diego Pharma and Much More Mar 21 2014 
      Ken Fisher for Forbes - 5 Fantastic Stocks for Fretters Jun 26 2013 
      Pfizer: A Strong Stock for 2013 Apr 20 2012 
      Maxygen Inc. (MAXY): A Magic Formula Stock to Avoid Feb 05 2009 


      More From Other Websites
      Bayer to early redeem EUR 1.3 billion bond issued in 2005 Apr 15 2015
      Bayer MaterialScience at UTECH 2015 -- Focus on a circular economy -- Committed to improving the... Apr 14 2015
      Bayer MaterialScience driving forward the use of carbon dioxide -- CO2 - a convincing new building... Apr 14 2015
      6:15 am Bayer AG announced two new Phase III trials to treat non-Hodgkin's lymphoma and One new... Apr 14 2015
      New Food Chain Partnership initiative started: -- Bayer CropScience and Farm Frites jointly... Apr 13 2015
      Monsanto, Bayer Join Venture-Capital Push Apr 06 2015
      Top First Quarter European ETFs Mar 31 2015
      Not intended for UK Media - Personalized Cardiology: -- Bayer HealthCare Expands Collaboration with... Mar 31 2015
      Bayer issues EUR 1.3 billion in hybrid capital Mar 30 2015
      Bayer AG -- Moody's assigns Baa2 rating to Bayer's new hybrid notes; stable outlook Mar 30 2015
      New polymer for transparent sun protection -- Baycusan® C 2000 delivers high SPF and feels pleasant... Mar 27 2015
      Regeneron's Eylea Gets FDA Approval for Label Expansion - Analyst Blog Mar 26 2015
      Bayer to present new preclinical, early clinical and epidemiological data on advancing portfolio in... Mar 24 2015
      Bayer MaterialScience at the in-cosmetics trade show in Barcelona -- The Beauty Enabler -- Relaunch... Mar 23 2015
      Bayer Furthers Global Efforts to Lead Fight Against Vector-Borne Diseases Mar 23 2015
      Merck Reports Encouraging Data from Cardiovascular Study - Analyst Blog Mar 17 2015
      How to trade the German DAX Mar 13 2015
      Bayer Seeks Eylea Label Expansion in the EU, Provides View - Analyst Blog Mar 12 2015
      Bayer Upbeat, Plans Chemicals IPO by 2016 Mar 11 2015
      Kythera's Double Chin Drug Backed by FDA Advisory Committee - Analyst Blog Mar 10 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK